Top compounds associated with response to PSMD9


Feature Type Standardized
Nominal ANOVA
mRNA lovastatin CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.001
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.003
mRNA PDMP CTRPv2 pan-cancer AAC -0.11 0.004
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.097 0.004
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.099 0.005
mRNA simvastatin CTRPv2 pan-cancer AAC 0.11 0.006
mRNA lapatinib UHNBreast pan-cancer AAC -0.7 0.007
Download CSV